MJNA
vs
S&P 500
MJNA
S&P 500
Over the past 12 months, MJNA has underperformed S&P 500, delivering a return of -50% compared to the S&P 500's +13% growth.
Stocks Performance
MJNA vs S&P 500
Performance Gap
MJNA vs S&P 500
Performance By Year
MJNA vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medical Marijuana Inc
Glance View
Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. The company is headquartered in Keizer, Oregon. The company went IPO on 2004-06-21. The Company, through its subsidiaries and investment holdings, focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil (Legal Hemp). The firm's products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale for the treatment of illnesses and conditions, and skin care products. The firm's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA’s subsidiaries include HempMedsPX, LLC, Red, CanChew Biotechnologies, LLC, Kannaway, LLC, and HempMeds Brazil.
